Kabushiki Kaisha Toyota Chuo Kenkyusho

Toyota Jidosha Kabushiki Kaisha

Chie Imamura

Satoshi Katahira

Kenro Tokuhiro

Akinori Ikeuchi

Toru Onishi

Hitoshi Yamada

Yuhei Yamaguchi

Nobuhiro Ishida

Nobuki Tada

Keiji Hayashi

Haruo Takahashi

Noriko Yasutani

Yoichiro Ito

Risa Nagura

Takashi Matsuyama

Mamoru Yamanishi

Nobuhiko Muramoto

Kiyomi Sakakibara

A mental and physical condition estimation system according to the present disclosure includes: a heart rate information acquisition unit for acquiring heart rate information that is information related to a heart rate of a subject person; a heart rate variability calculation unit for calculating heart rate variability of a very low frequency component (VLF) from the acquired heart rate information; and a mental and physical condition estimation unit for estimating a concentration and effort state of the subject person from a calculated value of the heart rate variability.

Mental and physical condition estimation system, mental and physical condition estimation method, and storage medium

A physiological state index calculation system, a physiological state index calculation method, and a non-transitory computer readable medium for capturing subtle changes in a physiological state of a living body are provided. The physiological state index calculation system includes a band-pass filter that filters cerebral blood flow waveform information obtained from a cerebral blood flow of a living body in at least one frequency band, and a complex number conversion unit configured to convert the filtered cerebral blood flow waveform information into a complex number for at least one frequency band. The cerebral blood flow waveform information converted into a complex number by the complex number conversion unit is an oscillator that reflects a physiological state of a living body.

Physiological state index calculation system, physiological state index calculation method, and non-transitory computer readable medium

A eukaryotic cell having xylose utilization ability. Provided is a protein that has xylose isomerase activity and has an amino acid sequence including, when aligned with an amino acid sequence expressed by SEQ ID NO:1, the 1st to 6th motifs expressed respectively by SEQ ID NOs:2 to 7 from the N-terminus side in the order described, and having, in place of asparagine (N) in an amino acid sequence of the 6th motif, another amino acid.

Protein having xylose isomerase activity and use of same

A method for producing an expression product of an exogenous gene in a yeast, including using at least one yeast gene terminator regions selected based on expression intensity data related to the expression intensity of yeast gene terminator regions to cause expression of a gene in a yeast.

Method for producing expression product of exogenous gene in yeast, regulator of expression in yeast, and use thereof

Provided is a method for producing an expression product of an exogenous gene in a yeast with superior output regulation of gene expression. This is a method for producing an expression product of an exogenous gene in a yeast, including using one or two or more kinds of yeast gene terminator regions selected based on expression intensity data related to the expression intensity of yeast gene terminator regions to cause expression of a gene in a yeast.

A cellobiohydrolase that can contribute to a synergistic effect on cellulose degradation and the use of such cellobiohydrolase in cellulose degradation are provided. The synergistic effect is achieved by an enzyme preparation for cellulose degradation containing a cellobiohydrolase originating inand belonging to GHF6 or a variant thereof, and an endoglucanase originating in a different source other than

[object Object]

The present teachings relate to an acid-resistant endoglucanase, which is a protein exhibiting excellent endoglucanase activity under acidic conditions. The present teachings provide a protein having the amino acid sequence set forth in SEQ ID NO: 2, a protein having an amino acid sequence with one or more amino acid modifications in the amino acid sequence set forth in SEQ ID NO: 2 and having endoglucanase activity, or a protein having an amino acid sequence with at least 75% homology to the amino acid sequence set forth in SEQ ID NO: 2 and having endoglucanase activity.

Growing community of inventors

Nagoya, Japan

Chie Imamura